Follow Us TR

News Details

Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-007 in Parkinson's Disease

About Seelos Therapeutics, Inc.
  • NASDAQ: $SEEL
  • Notified: $1.25
  • 08:02 EDT

Price Chart